Peptic ulcer primary prevention: Difference between revisions
Line 22: | Line 22: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
==References== | ==References== |
Revision as of 15:00, 4 June 2014
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Peptic ulcer Microchapters |
Diagnosis |
---|
Treatment |
Surgery |
Case Studies |
2017 ACG Guidelines for Peptic Ulcer Disease |
Guidelines for the Indications to Test for, and to Treat, H. pylori Infection |
Guidlines for factors that predict the successful eradication when treating H. pylori infection |
Guidelines to document H. pylori antimicrobial resistance in the North America |
Guidelines for evaluation and testing of H. pylori antibiotic resistance |
Guidelines for when to test for treatment success after H. pylori eradication therapy |
Guidelines for penicillin allergy in patients with H. pylori infection |
Peptic ulcer primary prevention On the Web |
American Roentgen Ray Society Images of Peptic ulcer primary prevention |
Risk calculators and risk factors for Peptic ulcer primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Primary Prevention
Lifestyle changes may help prevent peptic ulcers:
Tips include:
- Avoid aspirin, ibuprofen, naproxen, and other NSAIDs. Try acetaminophen instead. If you must take such medicines, talk to your doctor first.
- Don't smoke or chew tobacco.
- Limit alcohol to no more than two drinks per day.
PPI are indicated in patients who need for Antiplatelet Therapy, to minimize the risk of gastrointestinal bleeding:[1]
- History of ulcer complication.
- History of ulcer disease (non-bleeding).
- Dual antiplatelet therapy.
- Concomitant anticoagulant therapy
- More than one risk factor: ≥60 years, corticosteroid use, Dyspepsia or GERD symptoms.
References
- ↑ Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD; et al. (2008). "ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents". Circulation. 118 (18): 1894–909. doi:10.1161/CIRCULATIONAHA.108.191087. PMID 18836135.